Monday, June 15, 2026

South Korea’s President Says THAAD Shift to Middle East Won’t Weaken Defense

President Lee Jae Myung reassures that U.S. military relocations won't affect South Korea's defense against North Korea, emphasizing self-reliance.

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Chinese Company Caught on ‘Proxy Operating’ of DPRK Ships, Total of 19 Ships Violating Sanctions

Voice of America (VOA) reported on the...

Tag: Harrow

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.